GPhC Clears Pharmacist After Unsafe Online Opioid Dispensing Model Leads to Suspension
Date of Decision: November 17, 2025
Registrant's Role: Pharmacist
Allegations:
- Failed to ensure identity checks for patients requesting antimicrobials, high-risk, or monitored medicines.
- Did not audit or ensure audit of cancelled/refused medication requests.
- Allowed EU prescribers to prescribe in breach of GMC prescribing standards.
- Permitted patients to select POMs and alter consultation answers without audit trails.
- Failed to ensure prescribers had necessary information for safe prescribing.
- Did not manage risks of false patient information or appropriately share prescription info with GPs.
- Did not verify prescribers' indemnity cover or adherence to UK prescribing standards.
- Failed to perform adequate risk assessment of the pharmacy's distance-selling service.
- Displayed inadequate prescriber information on the pharmacy website.
- Allowed pharmacy website functionality to revert to allowing selection of medicine before consultation.
- Supplied dihydrocodeine to a patient without proper clinical oversight or GP consultation.
Outcome: Suspension to lapse on 2025-11-30; fitness to practise no longer impaired.
GPhC Standards Breached:
- Standard 1 – Provide person-centred care.
- Standard 2 – Work in partnership with others.
- Standard 4 – Maintain, develop and use professional knowledge and skills.
- Standard 5 – Use professional judgement.
- Standard 6 – Behave in a professional manner.
- Standard 7 – Respect and maintain the person’s confidentiality and privacy.
- Standard 8 – Speak up when you have concerns or when things go wrong.
Case Summary
Allegations
The case against the registrant centred on serious failings in his management of an online pharmacy, Pronto Healthcare, which operated between October 2018 and April 2021. Initially serving as the director and later as the superintendent pharmacist, the registrant oversaw a high-risk, distance-selling business model. The pharmacy primarily supplied opioid analgesics and sedatives—controlled medicines known for their potential for abuse—based on online questionnaires without any face-to-face consultations.
The allegations arose following a GPhC inspection prompted by concerns over inappropriate supply to a patient. The inspection revealed multiple breaches, including insufficient identity checks, failure to audit refused or cancelled medication orders, and allowing patients to self-select medication and modify consultation responses with no audit trail. Critically, the registrant engaged EU-based prescribers unregulated by the GMC or CQC, who prescribed without access to full medical histories, GP communication, or adequate justification—violating core GMC and GPhC guidance.
Continue Reading the Full Case
Create a free account or log in to access the complete case summary.
- Full allegations considered by the GPhC
- Panel findings and reasoning
- Outcome of the investigation
- Sanctions considered and imposed on the Pharmacist
- Key professional learning points
Original Case Document
View the Full Determination Document
The original determination transcript is available to registered users.
- Download the official GPhC determination
- Full hearing transcript
- Detailed findings of fact
- Sanction reasoning
- Details of the pharmacy professionals involved